“Age-Related Factors Affect Nivolumab and Ipilimumab Pharmacokinetics in Pediatric Cancer Patients”

https://pubmed.ncbi.nlm.nih.gov/38115545

This study found that, in addition to body size, age-related factors affect the population pharmacokinetics of nivolumab and ipilimumab in pediatric cancer patients, which can inform pediatric dosing recommendations for these medications.